Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Eli Lilly
(NY:
LLY
)
877.79
-31.53 (-3.47%)
Official Closing Price
Updated: 7:00 PM EDT, Sep 27, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Eli Lilly
< Previous
1
2
...
13
14
15
16
17
18
19
20
21
...
99
100
Next >
10 Health Care Stocks Whale Activity In Today's Session
June 24, 2024
Via
Benzinga
The Top 3 Sectors Poised For Growth This Summer
June 24, 2024
Communications, technology, and healthcare are the three hottest sectors for growth, but not all stocks will rise with the tides.
Via
MarketBeat
Topics
ETFs
ALT Stock Alert: Altimmune Pops on Weight-Loss Drug Findings
June 24, 2024
Altimmune (ALT) stock is soaring and trending after the company reported data on its GLP-1 weight-loss drug today.
Via
InvestorPlace
Eli Lilly's Weight-Loss Drug Takes Down ResMed, Inspire Medical — Again
June 24, 2024
Eli Lilly tested its weight-loss drug in people with obesity suffering from sleep apnea events.
Via
Investor's Business Daily
(LLY) - Analyzing Eli Lilly and Co's Short Interest
June 18, 2024
Via
Benzinga
Here's How Much $1000 Invested In Eli Lilly and Co 10 Years Ago Would Be Worth Today
June 18, 2024
Via
Benzinga
Eli Lilly's Zepbound For Weight Loss Shows Disease Resolution In Obese Sleep Apnea Patients, Lays Further Groundwork For Label Expansion
June 24, 2024
Eli Lilly's phase 3 SURMOUNT-OSA trials show tirzepatide injection significantly reduces apnea events in adults with obesity and moderate-to-severe obstructive sleep apnea. FDA decision expected by end...
Via
Benzinga
Exposures
Product Safety
AbbVie Inc. Dividend Stock Analysis - Saturday, June 22
June 22, 2024
Here are some highlights from a detailed, quantitative analysis AbbVie Inc. stock. Let's take a closer look at various factors, such as the stock's value and dividend.
Via
Talk Markets
MarketBeat Week in Review – 6/17 - 6/21
June 22, 2024
Markets were calmer this week, with the Dow index posting the biggest gains, but it's too early to tell if this is the start of a broader market rally
Via
MarketBeat
Topics
Economy
Stocks
Exposures
Interest Rates
US Equities
3 Biotech Stocks to Buy Now: June 2024
June 21, 2024
These are the three best biotech stocks to buy for long-term returns and portfolio stability due to their target patient populations,
Via
InvestorPlace
Gilead Sciences Faces Wall Street Speculation About Obesity Drugs Despite Focus On Liver Treatments
June 21, 2024
Gilead Sciences faces Wall Street speculation about its potential in the obesity drug market despite its focus on liver treatments.
Via
Benzinga
Lawsuit Could Challenge Trust In Ozempic And Other Popular Weight Loss Drugs
June 21, 2024
Weight loss drug manufacturers Novo Nordisk and Eli Lilly are being challenged in court. The companies are accused of failing to properly warn patients about associated risks.
Via
Talk Markets
Topics
Lawsuit
Exposures
Financial
Legal
Pre-Market Movers - June 21, 2024
June 21, 2024
Sarepta jumps after announcing expanded approval of DMD drug and more news on today's top movers.
Via
Talk Markets
Move Aside Ozempic, WeGovy: Denmark's New Drug Just Showed Positive Results For Weightloss
June 21, 2024
As per the official press release, the 16-week trial aimed to evaluate the safety, tolerability, and clinical effects of the drug called petrelintide.
Via
Benzinga
Hype Busters: 3 Overvalued Stocks Ready for a Reality Check
June 21, 2024
Discover three overvalued stocks that have completely lost touch with reality, with growth assumptions destined for disappointment.
Via
InvestorPlace
Nestle Carefully Targets Weight-Loss Drug Users with New Food Line
June 21, 2024
Nestle's new Vital Pursuit brand targets individuals on weight-loss drugs without mentioning medications on packaging, addressing regulatory concerns and focusing on marketing through social media.
Via
Benzinga
Forget Eli Lilly, Buy This Magnificent Biotech Stock Instead
June 21, 2024
Lilly is a good pick...but this one is better.
Via
The Motley Fool
Eli Lilly Has a New Drug That Could Push the Stock Higher
June 20, 2024
The Alzheimer’s treatment market is large and expected to grow.
Via
The Motley Fool
German Drug Developer Evotec Seeks Adviser Input As Takeover Concerns Mount
June 20, 2024
Evotec consults defense advisers following a significant share price decline, raising concerns about a potential takeover.
Via
Benzinga
Wall Street Favorites: 7 Growth Stocks With Strong Buy Ratings for June 2024
June 20, 2024
Investors hunting for stocks that will provide big gains should consider these top-rated growth stocks that have upside potential.
Via
InvestorPlace
Eli Lilly's Growth Prospects Just Got a Huge Upgrade
June 20, 2024
The company's promising Alzheimer's drug could soon obtain approval from regulators.
Via
The Motley Fool
Eli Lilly Expands Fight Against Counterfeit Obesity Drug Zepbound With New Legal Actions
June 20, 2024
Eli Lilly & Co has intensified its fight against counterfeit versions of its popular obesity drug, Zepbound, by initiating additional legal proceedings against companies selling compounded versions of...
Via
Benzinga
Eli Lilly's Stock Surge Driven by GLP-1 Demand
June 20, 2024
Shares of Eli Lilly stock are about to hit a new all-time high, sponsored by the pending approval of new weight loss drugs
Via
MarketBeat
Topics
Economy
Exposures
Interest Rates
10 Health Care Stocks Whale Activity In Today's Session
June 19, 2024
Via
Benzinga
Alzheimer's Drug Stocks: Investing in Eli Lilly, Biogen, Roche
June 19, 2024
The race to develop effective Alzheimer's treatments presents significant opportunities and inherent risks for healthcare investors.
Via
MarketBeat
Exposures
Product Safety
Eli Lilly Stock Analysis: Buy, Hold, or Sell?
June 19, 2024
Eli Lilly is ramping up manufacturing to meet the soaring demand for its innovative medicines.
Via
The Motley Fool
Eli Lilly Hits All-Time High, Named To Big Cap 20 List: Check These Lists For Best Stocks To Buy
June 18, 2024
Eli Lilly stock has been on an astounding run. In 2009 its stock sold for 27.21 a share. It closed Tuesday at 891.46, up 3,149% from 2009.
Via
Investor's Business Daily
The Best Biotech Stock to Invest $1,000 in Right Now
June 18, 2024
This stock may not be a slam dunk, but it's looking very promising.
Via
The Motley Fool
3 Strong Buy Stocks for a Sizzling Summer Rally
June 18, 2024
Investors can take a deep breath before the next earnings season, but they should still invest in equities, including these three gems hiding in plain sight
Via
MarketBeat
Topics
Artificial Intelligence
Economy
Exposures
Artificial Intelligence
Interest Rates
Gilead Has A Narrative-Changing Revelation For Its Weight-Loss Contender
June 17, 2024
The company tested a GLP-1 drug in monkeys. But it might not actually be an obesity treatment.
Via
Investor's Business Daily
< Previous
1
2
...
13
14
15
16
17
18
19
20
21
...
99
100
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.